These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2573159)

  • 1. [Effect of salazosulfapyridine and its metabolites on immunocompetent cells].
    Ishibashi T; Hara A; Tsuboi I; Muraoka T; Shibata H; Tsunosue R; Shichijo S; Yokoyama M
    Ryumachi; 1989 Jun; 29(3):178-84. PubMed ID: 2573159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I; Kumamoto T; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of sulfasalazine and its metabolites on prostaglandin and leukotriene liberation from human synovial tissue].
    Wittenberg HR; Kleemeyer K; Peskar BM; Peskar BA
    Wien Klin Wochenschr; 1991; 103(2):34-9. PubMed ID: 1673814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oxygen-centered radicals scavenging activity of sulfasalazine and its metabolites. A direct protection of the bowel.
    Prónai L; Yukinobu I; Láng I; Fehér J
    Acta Physiol Hung; 1992; 80(1-4):317-23. PubMed ID: 1364279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
    Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of salazosulfapyridine in a hemodialysis patient].
    Akiyama Y; Fujimaki T; Sakurai Y
    Ryumachi; 2003 Jun; 43(3):569-76. PubMed ID: 12910967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
    Zheng W; Winter SM; Mayersohn M; Bishop JB; Sipes IG
    Drug Metab Dispos; 1993; 21(6):1091-7. PubMed ID: 7905389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sulfasalazine and its metabolites on steady state messenger RNA concentrations for inflammatory cytokines, matrix metalloproteinases, and tissue inhibitors of metalloproteinase in rheumatoid synovial fibroblasts.
    Minghetti PP; Blackburn WD
    J Rheumatol; 2000 Mar; 27(3):653-60. PubMed ID: 10743803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminosalicylic acid abrogates T-cell proliferation by blocking interleukin-2 production in peripheral blood mononuclear cells.
    Stevens C; Lipman M; Fabry S; Moscovitch-Lopatin M; Almawi W; Keresztes S; Peppercorn MA; Strom TB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):399-406. PubMed ID: 7815356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells.
    Bissonnette EY; Enciso JA; Befus AD
    J Immunol; 1996 Jan; 156(1):218-23. PubMed ID: 8598465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
    Aono H; Hasunuma T; Fujisawa K; Nakajima T; Yamamoto K; Mita S; Nishioka K
    J Rheumatol; 1996 Jan; 23(1):65-70. PubMed ID: 8838510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
    Christensen LA
    Dan Med Bull; 2000 Feb; 47(1):20-41. PubMed ID: 10709142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine metabolite pharmacokinetics in pediatric patients with inflammatory bowel disease: effects of disease activity, acetylator phenotype, and age.
    Clarke DF; George D; Milsap RL; Pogonowska-Wala E; Owerbach J; Lebenthal E; Jusko WJ
    Pediatr Pharmacol (New York); 1982; 2(4):323-33. PubMed ID: 6152489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
    Sheldon P; Webb C; Grindulis KA
    Br J Rheumatol; 1988 Oct; 27(5):344-9. PubMed ID: 2902897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proliferative responses and interleukin 2 productions by salazosulfapyridine and its metabolites.
    Fujiwara M; Mitsui K; Yamamoto I
    Jpn J Pharmacol; 1990 Oct; 54(2):121-31. PubMed ID: 1981793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifolate actions of sulfasalazine on intact lymphocytes.
    Baum CL; Selhub J; Rosenberg IH
    J Lab Clin Med; 1981 Jun; 97(6):779-84. PubMed ID: 6112249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release.
    Loetscher P; Seitz M; Clark-Lewis I; Baggiolini M; Moser B
    J Immunol; 1996 Jan; 156(1):322-7. PubMed ID: 8598480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.